These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34009532)

  • 1. Modulating Oral Delivery and Gastrointestinal Kinetics of Recombinant Proteins via Engineered Fungi.
    Heavey MK; Anselmo AC
    AAPS J; 2021 May; 23(4):76. PubMed ID: 34009532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living recombinant Saccharomyces cerevisiae secreting proteins or peptides as a new drug delivery system in the gut.
    Blanquet S; Antonelli R; Laforet L; Denis S; Marol-Bonnin S; Alric M
    J Biotechnol; 2004 May; 110(1):37-49. PubMed ID: 15099904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and delivery strategies for engineered live biotherapeutic products.
    Heavey MK; Durmusoglu D; Crook N; Anselmo AC
    Trends Biotechnol; 2022 Mar; 40(3):354-369. PubMed ID: 34481657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically engineered yeasts as a new delivery vehicle of active compounds to the digestive tract: in vivo validation of the concept in the rat.
    Garrait G; Jarrige JF; Blanquet-Diot S; Alric M
    Metab Eng; 2009 May; 11(3):148-54. PubMed ID: 19344650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from the clinical development of oral peptides.
    Karsdal MA; Riis BJ; Mehta N; Stern W; Arbit E; Christiansen C; Henriksen K
    Br J Clin Pharmacol; 2015 May; 79(5):720-32. PubMed ID: 25408230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cryoprotectants on the viability and activity of freeze dried recombinant yeasts as novel oral drug delivery systems assessed by an artificial digestive system.
    Blanquet S; Garrait G; Beyssac E; Perrier C; Denis S; Hébrard G; Alric M
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):32-9. PubMed ID: 16005198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of genetically modified bacteria for drug delivery in humans: Revisiting the safety aspect.
    Wegmann U; Carvalho AL; Stocks M; Carding SR
    Sci Rep; 2017 May; 7(1):2294. PubMed ID: 28536456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral delivery of protein-based therapeutics: Gastroprotective strategies, physiological barriers and in vitro permeability prediction.
    Wright L; Barnes TJ; Prestidge CA
    Int J Pharm; 2020 Jul; 585():119488. PubMed ID: 32504774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative model for metabolic intervention using gut microbes.
    Mays ZJS; Nair NU
    Biotechnol Prog; 2021 Sep; 37(5):e3125. PubMed ID: 33426814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes.
    Cano-Garrido O; Seras-Franzoso J; Garcia-Fruitós E
    Microb Cell Fact; 2015 Sep; 14():137. PubMed ID: 26377321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SiRNA In Vivo-Targeted Delivery to Murine Dendritic Cells by Oral Administration of Recombinant Yeast.
    Xu K; Liu Z; Zhang L; Zhang T; Zhang Z
    Methods Mol Biol; 2016; 1364():165-81. PubMed ID: 26472450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Saccharomyces cerevisiae strain expressing a model cytochrome P450 in the rat digestive environment: viability and bioconversion activity.
    Garrait G; Jarrige JF; Blanquet S; Beyssac E; Alric M
    Appl Environ Microbiol; 2007 Jun; 73(11):3566-74. PubMed ID: 17416683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Surface Modified Live Biotherapeutic Products for Oral Delivery.
    Vargason AM; Anselmo AC
    ACS Biomater Sci Eng; 2023 Jun; 9(6):2868-2878. PubMed ID: 33378160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant lactic acid bacteria as mucosal biotherapeutic agents.
    Daniel C; Roussel Y; Kleerebezem M; Pot B
    Trends Biotechnol; 2011 Oct; 29(10):499-508. PubMed ID: 21665301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.
    Hudson LE; Fasken MB; McDermott CD; McBride SM; Kuiper EG; Guiliano DB; Corbett AH; Lamb TJ
    PLoS One; 2014; 9(11):e112660. PubMed ID: 25391025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: An UNGAP review.
    Vertzoni M; Augustijns P; Grimm M; Koziolek M; Lemmens G; Parrott N; Pentafragka C; Reppas C; Rubbens J; Van Den Αbeele J; Vanuytsel T; Weitschies W; Wilson CG
    Eur J Pharm Sci; 2019 Jun; 134():153-175. PubMed ID: 30991092
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Durmusoglu D; Al'Abri IS; Collins SP; Cheng J; Eroglu A; Beisel CL; Crook N
    ACS Synth Biol; 2021 May; 10(5):1039-1052. PubMed ID: 33843197
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
    Ensign LM; Cone R; Hanes J
    Adv Drug Deliv Rev; 2012 May; 64(6):557-70. PubMed ID: 22212900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Navigating the human gastrointestinal tract for oral drug delivery: Uncharted waters and new frontiers.
    Koziolek M; Grimm M; Schneider F; Jedamzik P; Sager M; Kühn JP; Siegmund W; Weitschies W
    Adv Drug Deliv Rev; 2016 Jun; 101():75-88. PubMed ID: 27037063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of whey protein beads as a new carrier system for recombinant yeasts in human digestive tract.
    Hébrard G; Blanquet S; Beyssac E; Remondetto G; Subirade M; Alric M
    J Biotechnol; 2006 Dec; 127(1):151-60. PubMed ID: 16962195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.